Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baxter InternationalHAM:BTL +4.64%59 5-Year Yield-on-Cost % is 0.59 as of Jul. 16, 2026, which is 25% below its 10-year median of 0.79. GuruFocus rates HAM:BTL with a GF Score™ of 59/100 and a GF Value™ of €28.92 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 325 Medical Devices & Instruments companies, Baxter International ranks worse than 85.54% on this metric.
Baxter International's yield on cost for the quarter that ended in Mar. 2026 was 0.59.
The historical rank and industry rank for Baxter International's 5-Year Yield-on-Cost % or its related term are showing as below:
HAM:BTL'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.54 Med: 0.79 Max: 2.53
Current: 0.59
During the past 13 years, Baxter International's highest Yield on Cost was 2.53. The lowest was 0.54. And the median was 0.79.
HAM:BTL's 5-Year Yield-on-Cost % is ranked worse than 85.54% of 325
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs HAM:BTL: 0.59
Baxter International (HAM:BTL) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Baxter International 5-Year Yield-on-Cost % Related Terms
HAM:BTL vs ALGN, SOLV, COO: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Baxter International's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Baxter International's 5-Year Yield-on-Cost % falls into.
Baxter International 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Baxter International (HAM:BTL) has a 5-Year Yield-on-Cost % of 0.59 as of Jul. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Baxter International and its competitors. This is 25% below median its historical median of 0.79. Over the past decade, Baxter International's 5-Year Yield-on-Cost % has ranged from 0.54 to 2.53. According to the industry distribution chart, Baxter International ranks #278 out of 325 companies in the Medical Devices & Instruments industry, placing it in the top 85.5%.
Is Baxter International's 5-Year Yield-on-Cost % too high?
Baxter International's current 5-Year Yield-on-Cost % of 0.59 is 25% below median its 10-year median of 0.79. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 2.53. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.31. Baxter International's value of 0.59 is 74.5% below this industry median. Based on the distribution chart, Baxter International ranks #278 out of 325 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Baxter International has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's 5-Year Yield-on-Cost % compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #278 out of 325 companies for 5-Year Yield-on-Cost %. This places Baxter International in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.31. Baxter International's value of 0.59 is 74.5% below this benchmark. Historically, Baxter International's own 5-Year Yield-on-Cost % has ranged from 0.54 to 2.53 over the past decade. While the company's 10-year median is 0.79 vs. the industry median of 2.31, Baxter International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baxter International's current 5-Year Yield-on-Cost % of 0.59 is 74.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Baxter International and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baxter International's current 5-Year Yield-on-Cost % is 0.59, which is 25% below median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (HAM:BTL) is currently considered Possible Value Trap. The stock's GF Value™ is €28.92, compared to a current price of €19.51 — trading 32.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.59, which is 25% below median its 10-year median of 0.79 and 74.5% below the Medical Devices & Instruments industry median of 2.31. Baxter International's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Baxter International (HAM:BTL), the current 5-Year Yield-on-Cost % is 0.59 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (HAM:BTL) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of €19.51 is trading 32.6% below its estimated GF Value™ of €28.92.
GuruFocus considers Baxter International to be Possible Value Trap.
Key valuation signals for HAM:BTL:
5-Year Yield-on-Cost %: 0.59 (25% below median its 10-year median of 0.79)
GF Value™: €28.92 vs. price of €19.51 (32.6% below fair value)
Industry Position: 74.5% below the Medical Devices & Instruments median (#278 of 325)
No single metric tells the full story. See the HAM:BTL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
59GF Score
Get the complete analysis for HAM:BTL
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:BTL has been successfully added to your 
